U.S. Pharma Stock News

NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna (MRNA) Valuation Check After Global Settlement On Lipid Nanoparticle Patent Disputes

Moderna (MRNA) is back in focus after agreeing to a global settlement of up to US$2.25b with Arbutus Biopharma and Genevant Sciences over lipid nanoparticle patents tied to its COVID-19 and RSV vaccines. See our latest analysis for Moderna. That settlement headlines a sharp shift in sentiment, with a 90 day share price return of 94.33% and year to date gain of 74.43% contrasting with a 3 year total shareholder return loss of 60.81%. This suggests that recent momentum is rebuilding after a...
NYSE:VLO
NYSE:VLOOil and Gas

Valero Capital Raise And Dividend Hike Contrast With Rich Share Price

Valero Energy (NYSE:VLO) has completed a significant fixed-income offering. The company has announced a sizable quarterly dividend increase for shareholders. These moves come as refining margins are supported by geopolitical tensions and regulatory shifts. Valero Energy, a major independent refiner and marketer, sits at the center of global fuel flows, so changes in its balance sheet and dividend policy tend to matter to income focused and total return investors alike. With refining margins...
NYSE:SAFE
NYSE:SAFESpecialized REITs

Assessing Safehold (SAFE) Valuation After Recent Share Price Pullback And Mixed Performance

What Safehold’s recent performance means for stock watchers Safehold (SAFE) has been drawing attention after a recent move in its share price, with the stock closing at US$15.52 and showing mixed returns over the past year and past 3 months. Short term performance has been softer, with a 1 day return of about a 1.2% decline and a 7 day return of about a 5.1% decline, while the month return sits near 10% and the past 3 months around 15.4%. See our latest analysis for Safehold. For context,...
NasdaqGS:ZION
NasdaqGS:ZIONBanks

A Look At Zions Bancorporation (ZION) Valuation After Recent Technology Leadership Changes

Zions Bancorporation National Association (ZION) is in focus after announcing a reshuffle in its technology leadership, with long‑time Chief Technology and Operations Officer Jennifer Smith departing and her responsibilities split between Margaret Mayer and Ken Collins. See our latest analysis for Zions Bancorporation National Association. Those technology leadership changes arrive after a softer recent patch for the shares, with a 7 day share price return of 6.8% and a 30 day share price...
NasdaqGS:FLEX
NasdaqGS:FLEXElectronic

Flex Deepens AMD Ties As U.S. AI Data Center Role Grows

Flex (NasdaqGS:FLEX) has expanded its manufacturing partnership with AMD to produce AMD Instinct platforms for AI data centers in the U.S. Production is set to take place at Flex's Austin facility, adding domestic capacity for advanced AI GPUs. The move aligns Flex more closely with the build out of AI infrastructure and U.S. technology supply chain priorities. Flex, trading at $63.51, has seen its share price move sharply over the past few years, including a very large 3 year return and a...
NYSE:APD
NYSE:APDChemicals

Short Interest Eases As Air Products Trades Near Fair Value Estimates

Short interest in Air Products and Chemicals has recently declined as a share of float. The company's short interest now sits below the average level seen among industry peers. This change points to reduced bearish positioning in NYSE:APD and a shift in how traders are viewing the stock. For you as an investor, that move in short interest adds an extra layer to how you might look at NYSE:APD alongside its share price of $276.35. The stock is roughly flat over the past week with a 0.0%...
NasdaqGS:ODFL
NasdaqGS:ODFLTransportation

Is Old Dominion (ODFL) Using Yield Discipline And Buybacks To Redefine Its Profitability Playbook?

Old Dominion Freight Line recently reported that February 2026 revenue per day fell 3.3% year over year as LTL tons per day declined 6.8%, while quarter‑to‑date LTL revenue per hundredweight increased 3.5% on the back of disciplined yield management. Management coupled this moderating volume weakness with a new share repurchase program, base rate increases, and fresh service‑center capacity, signaling confidence in the company’s ability to capture profitable freight when demand...
NasdaqGS:EQIX
NasdaqGS:EQIXSpecialized REITs

A Look At Equinix (EQIX) Valuation After Recent Share Price Strength And Premium P/E Multiple

Equinix (EQIX) is back on investor radars today after a recent share move that leaves the stock trading near $953. Attention is centering on how its data center business supports ongoing revenue and net income growth. See our latest analysis for Equinix. That recent move to a US$953 share price comes after a 30 day share price return of 18.85% and a 90 day gain of 28.51%. The 5 year total shareholder return of 60.48% points to momentum that has built over time. If Equinix’s run has you...
NYSE:UAA
NYSE:UAALuxury

Under Armour Taps SXSW Jacket To Highlight Sustainability And Valuation Story

UNLESS COLLECTIVE, a subsidiary of Under Armour (NYSE:UAA), has been selected as the partner for SXSW's first official Filmmakers Jacket. The collaboration centers on a plant-based, regenerative festival jacket created for SXSW's 2026 event. This represents a move for Under Armour into higher profile sustainable festival merchandise tied to a major cultural gathering. Under Armour, best known for performance athletic wear, is using UNLESS COLLECTIVE to expand into eco-focused apparel tied...
NYSE:WMB
NYSE:WMBOil and Gas

What Williams Companies (WMB)'s Long‑Term EBITDA Outlook and Dividend Hike Means For Shareholders

In recent months, Williams Companies held an Analyst Day where management outlined a projected five-year EBITDA compound annual growth rate above 10% through 2025 and 2030, supported by projects that already have final investment decisions and moderate gathering and processing growth. Alongside these long-term growth projections, Williams increased its quarterly dividend and drew a wave of fresh analyst research, highlighting how its core natural gas infrastructure underpins power...
NasdaqGS:FRSH
NasdaqGS:FRSHSoftware

Freshworks Unifies Revenue Teams Under New Leader As Guidance Reaffirmed

Freshworks (NasdaqGS:FRSH) has reorganized its global sales leadership, appointing Ian Tickle as Chief Revenue Officer. The move coincides with the departure of senior executive Mika Yamamoto from the company. The change aligns all global sales operations under a single revenue leader for the next phase of execution. Freshworks, best known for its customer support, sales, and IT service software, sits in a crowded market where vendors are competing on ease of use, pricing, and integration...
NYSE:AIN
NYSE:AINMachinery

Should Albany International’s Mixed Q4 Results and Capital Moves Require Action From AIN Investors?

In late February 2026, Albany International Corp. reported fourth-quarter 2025 sales of US$321.21 million with lower net income, issued first-quarter 2026 revenue guidance of US$275 million to US$285 million, completed a share repurchase program, filed a US$57.96 million shelf registration for an ESOP-related offering, and previously declared a US$0.28 quarterly dividend payable April 7, 2026. Together, these actions show Albany International balancing capital returns and employee ownership...
NYSE:BVN
NYSE:BVNMetals and Mining

Is Buenaventura’s (BVN) Bigger Dividend Payout Recasting Its Capital Allocation Story?

Compañía de Minas Buenaventura S.A.A. recently reported past fourth-quarter 2025 revenue of US$623.4 million and net income of US$383.61 million, and its board proposed a dividend of US$0.9904 per share/ADS. The sharp year-on-year jump in quarterly earnings, alongside a new cash dividend proposal, highlights a period of significantly stronger profitability and capital return capacity. Next, we'll examine how this stronger profitability and the proposed US$0.9904 per share dividend reshape...
NasdaqGS:QS
NasdaqGS:QSAuto Components

How Investors Are Reacting To QuantumScape (QS) Board Shakeup And HSBC’s Broader Solid-State Battery View

QuantumScape recently appointed defense-sector veteran Ross Niebergall to its board of directors, adding deep aerospace and defense R&D and commercialization experience to its leadership. At the same time, HSBC’s upgrade and focus on QuantumScape’s push into applications such as robotics, data centers, aviation, and defense highlights how its solid-state battery technology story is broadening beyond autos. We’ll now examine how HSBC’s recognition of QuantumScape’s expanding non-automotive...
NasdaqGS:TXN
NasdaqGS:TXNSemiconductor

Is It Time To Reassess Texas Instruments (TXN) After The Recent Share Price Pullback

If you are wondering whether Texas Instruments at around US$197.98 is offering fair value or a potential bargain right now, this article will walk you through that question step by step. The stock has recently been volatile, with a 6.9% decline over the last 7 days and a 12.1% decline over the last 30 days, even though returns sit at 11.5% year to date and 7.9% over 1 year, extending to 24.9% over 3 years and 30.5% over 5 years. Recent coverage has focused on Texas Instruments as an...
NasdaqGS:STGW
NasdaqGS:STGWMedia

Is Stagwell’s (STGW) New AI Search Platform a Turning Point in Its Competitive Positioning?

In early March 2026, Stagwell’s media agency Assembly and AI partner Emberos launched Stagwell Search+, an agentic platform designed to improve brand performance across emerging AI search experiences by unifying audit, intelligence, and cross-channel activation. The launch highlights Stagwell’s push to systematize AI-driven visibility and sentiment management across paid, owned, earned, and shared media, moving beyond traditional SEO tweaks as AI models increasingly mediate consumer choice...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

How Investors Are Reacting To Biogen (BIIB) Advancing Salanersen And Expanding Its SMA Franchise

In early March 2026, Biogen announced new and long-term data from its spinal muscular atrophy programs, including high‑dose nusinersen and the investigational therapy salanersen, alongside updates on biomarker work and global regulatory reviews for an additional dosing option of SPINRAZA. Separately, Biogen and Stoke Therapeutics reported published clinical results on zorevunersen in Dravet syndrome, highlighting multi‑year seizure reductions and functional gains that support ongoing...
NasdaqGS:MRX
NasdaqGS:MRXCapital Markets

Marex Group Webb Traders Deal Expands Equity Derivatives And Valuation Upside

Marex Group (NasdaqGS:MRX) has agreed to acquire Webb Traders, expanding its equity derivatives trading and risk management capabilities. The deal is intended to strengthen Marex's ability to internalize risk hedging and support its conservative risk approach. The transaction marks a material step in building out Marex's platform beyond routine operational updates. Marex Group, trading on the NasdaqGS under ticker MRX, last closed at $38.52. The shares are up 7.9% over the past year, while...
NasdaqGS:MANH
NasdaqGS:MANHSoftware

A Look At Manhattan Associates (MANH) Valuation After Conference Update On Bookings And Cloud Growth

Manhattan Associates (MANH) has been back on investors’ radar after management used the 47th Annual Raymond James Institutional Investor Conference to highlight record fourth quarter bookings, strong new customer contributions, and confidence in cloud revenue growth. See our latest analysis for Manhattan Associates. At a share price of US$147.00, Manhattan Associates has seen a 5.29% 7 day share price return and an 8.38% 30 day share price return. Its year to date share price return of 12.12%...
NasdaqCM:FRHC
NasdaqCM:FRHCCapital Markets

Is Freedom Holding (FRHC) Pricing Make Sense After Recent Regulatory Scrutiny And Strong Multi‑Year Gains

If you are wondering whether Freedom Holding's current share price reflects its real worth, you are not alone. This article is designed to walk you through what the numbers are actually saying about its value. The stock last closed at US$130.66, with returns of 9.3% over 7 days, 8.3% over 30 days, 5.2% year to date, a 4.9% decline over 1 year, and gains of 83.3% over 3 years and 145.2% over 5 years. Recent coverage around Freedom Holding has focused on its business model and regulatory...
NYSE:DVA
NYSE:DVAHealthcare

DaVita Confronts Volume Pressure While Expanding Integrated Kidney Care Model

DaVita (NYSE:DVA) is contending with declining patient volumes that are weighing on its core dialysis operations. The company is responding by putting more resources into clinical programs and integrated kidney care offerings. These initiatives are intended to reshape how DaVita serves patients over the coming years, with implications for its business mix and cost profile. DaVita, trading around $149.94, sits at an important inflection point as it works through this pressure on its dialysis...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

Assessing Fastly (FSLY) Valuation After AI‑Driven Growth Pitch Rekindles Investor Optimism

Why Fastly Stock Is Back in Focus After Investor Meetings Fastly (FSLY) moved back onto investors’ radar after management used recent institutional investor meetings and a conference appearance to lay out its product roadmap and the role of AI driven traffic in its edge cloud business. See our latest analysis for Fastly. Those investor meetings and conference comments have come on the back of a sharp shift in sentiment, with a 30 day share price return of 132.54% and a 1 year total...
NYSE:LNC
NYSE:LNCInsurance

A Look At Lincoln National (LNC) Valuation After Wells Fargo Upgrade And Rebuilt Balance Sheet

Lincoln National (LNC) is back on investors’ radar after Wells Fargo upgraded the stock, citing stronger cash flow, a rebuilt balance sheet, and the potential for earlier than expected share repurchases. See our latest analysis for Lincoln National. Despite the Wells Fargo upgrade and recent analyst attention, Lincoln National’s share price has declined 13.71% over the past 30 days and 21.95% year to date. In contrast, the 3 year total shareholder return of 54.04% indicates that longer term...
NasdaqGS:ICLR
NasdaqGS:ICLRLife Sciences

How Investors May Respond To ICON (ICLR) Accounting Overstatement And Withdrawn 2025 Guidance

In recent days, ICON plc reported that an internal Audit Committee investigation found revenue for 2023 and 2024 had been overstated by less than two percent, prompting the withdrawal of its prior 2025 full-year financial guidance. Following this clarification, multiple Wall Street analysts upgraded ICON’s rating, arguing that earlier accounting concerns now appear largely reflected in the company’s valuation. With analysts suggesting the accounting overstatement was relatively limited,...